Published in Arch Neurol on March 01, 2009
VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis. FASEB J (2011) 0.96
Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis. Radiology (2014) 0.93
Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice. Am J Pathol (2013) 0.87
The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models. Neuroimage (2010) 0.86
Advanced MRI in multiple sclerosis: current status and future challenges. Neurol Clin (2011) 0.83
Imaging outcomes for trials of remyelination in multiple sclerosis. J Neurol Neurosurg Psychiatry (2014) 0.82
Diffusion tensor imaging for understanding brain development in early life. Annu Rev Psychol (2015) 0.80
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study. J Neurol (2014) 0.80
Remyelination Therapy in Multiple Sclerosis. Front Neurol (2015) 0.79
Role of glial 14-3-3 gamma protein in autoimmune demyelination. J Neuroinflammation (2015) 0.75
Edaravone reduces astrogliosis and apoptosis in young rats with kaolin-induced hydrocephalus. Childs Nerv Syst (2016) 0.75
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med (2008) 12.90
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med (2012) 7.58
Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage (2008) 6.58
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet (2012) 4.25
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet (2012) 3.89
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol (2014) 2.51
Dissociating the human language pathways with high angular resolution diffusion fiber tractography. J Neurosci (2008) 2.50
Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21
MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol (2011) 2.12
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol (2011) 1.92
Growth of white matter in the adolescent brain: role of testosterone and androgen receptor. J Neurosci (2008) 1.91
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Hemodynamic and metabolic responses to neuronal inhibition. Neuroimage (2004) 1.88
Flow-based fiber tracking with diffusion tensor and q-ball data: validation and comparison to principal diffusion direction techniques. Neuroimage (2005) 1.87
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol (2007) 1.86
The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol (2004) 1.76
Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci (2013) 1.74
EEG-fMRI of focal epileptic spikes: analysis with multiple haemodynamic functions and comparison with gadolinium-enhanced MR angiograms. Hum Brain Mapp (2004) 1.68
T(2) relaxometry of normal pediatric brain development. J Magn Reson Imaging (2009) 1.60
Global cerebral oxidative metabolism during hypercapnia and hypocapnia in humans: implications for BOLD fMRI. J Cereb Blood Flow Metab (2010) 1.60
Twenty new digital brain phantoms for creation of validation image data bases. IEEE Trans Med Imaging (2006) 1.55
Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas. Neurosurgery (2003) 1.54
Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder. Brain (2004) 1.54
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging. Med Image Anal (2012) 1.50
Seeing injectable MS therapies differently: they are more similar than different. Neurology (2009) 1.47
Maternal cigarette smoking during pregnancy predicts drug use via externalizing behavior in two community-based samples of adolescents. Addiction (2014) 1.43
The effect of global cerebral vasodilation on focal activation hemodynamics. Neuroimage (2005) 1.41
Prenatal exposure to maternal cigarette smoking and the adolescent cerebral cortex. Neuropsychopharmacology (2007) 1.33
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med (2015) 1.28
Morphological properties of the action-observation cortical network in adolescents with low and high resistance to peer influence. Soc Neurosci (2008) 1.28
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol (2013) 1.27
Hemodynamic and metabolic responses to activation, deactivation and epileptic discharges. Neuroimage (2005) 1.22
2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol (2012) 1.21
Persistent organic pollutant residues in human fetal liver and placenta from Greater Montreal, Quebec: a longitudinal study from 1998 through 2006. Environ Health Perspect (2008) 1.20
Sensitivity of voxel-based morphometry analysis to choice of imaging protocol at 3 T. Neuroimage (2008) 1.19
BOLD-specific cerebral blood volume and blood flow changes during neuronal activation in humans. NMR Biomed (2009) 1.17
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study. J Neurol (2013) 1.17
Characterizing healthy and diseased white matter using quantitative magnetization transfer and multicomponent T(2) relaxometry: A unified view via a four-pool model. Magn Reson Med (2009) 1.17
Lesion distribution in children with clinically isolated syndromes. Ann Neurol (2008) 1.17
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol (2008) 1.16
Human whole blood T2 relaxometry at 3 Tesla. Magn Reson Med (2009) 1.13
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol (2012) 1.13
Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. Neuroimage (2010) 1.10
Precise control of end-tidal carbon dioxide and oxygen improves BOLD and ASL cerebrovascular reactivity measures. Magn Reson Med (2010) 1.10
Improved fMRI calibration: precisely controlled hyperoxic versus hypercapnic stimuli. Neuroimage (2010) 1.08
Clinically feasible MTR is sensitive to cortical demyelination in MS. Neurology (2012) 1.07
Automated detection of focal cortical dysplasia lesions using computational models of their MRI characteristics and texture analysis. Neuroimage (2003) 1.07
1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain (2005) 1.07
Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol (2002) 1.07
MRI measurement of the BOLD-specific flow-volume relationship during hypercapnia and hypocapnia in humans. Neuroimage (2010) 1.06
Origins of the BOLD post-stimulus undershoot. Neuroimage (2009) 1.06
Labeling of ambiguous subvoxel fibre bundle configurations in high angular resolution diffusion MRI. Neuroimage (2008) 1.06
Quantitative analysis of temporal lobe white matter T2 relaxation time in temporal lobe epilepsy. Neuroimage (2004) 1.04
Evidence against the involvement of chronic cerebrospinal venous abnormalities in multiple sclerosis. A case-control study. PLoS One (2013) 1.04
Human whole-blood relaxometry at 1.5 T: Assessment of diffusion and exchange models. Magn Reson Med (2004) 1.04
Quantitative magnetization transfer and myelin water imaging of the evolution of acute multiple sclerosis lesions. Magn Reson Med (2010) 1.03
Trimmed-likelihood estimation for focal lesions and tissue segmentation in multisequence MRI for multiple sclerosis. IEEE Trans Med Imaging (2011) 1.03
Elevated serum inflammatory markers in post-poliomyelitis syndrome. J Neurol Sci (2008) 1.03
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. Biol Blood Marrow Transplant (2010) 1.02
The serum S100B concentration is age dependent. Clin Chem (2002) 1.01
Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group. J Magn Reson Imaging (2005) 0.99
Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus. Clin Rev Allergy Immunol (2008) 0.99
Regional impact of field strength on voxel-based morphometry results. Hum Brain Mapp (2010) 0.99
Streamline flows for white matter fibre pathway segmentation in diffusion MRI. Med Image Comput Comput Assist Interv (2008) 0.99
Accelerating parameter mapping with a locally low rank constraint. Magn Reson Med (2014) 0.99
The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study. J Magn Reson Imaging (2005) 0.99
A multi-modal approach to computer-assisted deep brain stimulation trajectory planning. Int J Comput Assist Radiol Surg (2012) 0.98
Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T. Neuroimage (2013) 0.98
Evidence for a virtual human analog of a rodent relational memory task: a study of aging and fMRI in young adults. Hippocampus (2011) 0.97
Computational models of MRI characteristics of focal cortical dysplasia improve lesion detection. Neuroimage (2002) 0.97
Venous refocusing for volume estimation: VERVE functional magnetic resonance imaging. Magn Reson Med (2005) 0.97
Entorhinal cortex MRI assessment in temporal, extratemporal, and idiopathic generalized epilepsy. Epilepsia (2003) 0.97
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study. Mult Scler (2013) 0.96
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. J Neuroimmunol (2006) 0.96
Evaluating intensity normalization on MRIs of human brain with multiple sclerosis. Med Image Anal (2010) 0.96
Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study. J Psychiatr Res (2010) 0.96
On the accuracy of T1 mapping: searching for common ground. Magn Reson Med (2014) 0.95